
One to watch: How Aulos is advancing immunotherapy cancer treatments
DDW Editor Reece Armstrong speaks to Aron Knickerbocker, CEO of Aulos Bioscience, about the company’s efforts in the immuno-oncology field and how it is hoping to revitalise a therapeutic area that initially held promise many years ago. The number of available treatment options for cancer patients has risen drastically… Read More















